These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1331571)
1. Tumor-infiltrating lymphocytes and prognosis of hepatocellular carcinoma. Kawata A; Une Y; Hosokawa M; Uchino J; Kobayashi H Jpn J Clin Oncol; 1992 Aug; 22(4):256-63. PubMed ID: 1331571 [TBL] [Abstract][Full Text] [Related]
2. Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. Belldegrun A; Muul LM; Rosenberg SA Cancer Res; 1988 Jan; 48(1):206-14. PubMed ID: 3257161 [TBL] [Abstract][Full Text] [Related]
3. [The relationship between TIL from human primary hepatic carcinoma and prognosis]. Qin J; Han B; Pang J Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):167-70. PubMed ID: 9596951 [TBL] [Abstract][Full Text] [Related]
4. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2. Kooi S; Zhang HZ; Patenia R; Edwards CL; Platsoucas CD; Freedman RS Cell Immunol; 1996 Dec; 174(2):116-28. PubMed ID: 8954611 [TBL] [Abstract][Full Text] [Related]
5. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620 [TBL] [Abstract][Full Text] [Related]
6. Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors. Heo DS; Whiteside TL; Kanbour A; Herberman RB J Immunol; 1988 Jun; 140(11):4042-9. PubMed ID: 3286766 [TBL] [Abstract][Full Text] [Related]
7. [Effects of auto-tumor infiltrating lymphocytes induced by interleukin (IL)-12 with IL-2 on patients of primary hepatic carcinoma]. Zhang YX; Wang XY; Liu JB; Zhang SQ; Chen YR Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):973-6. PubMed ID: 18756970 [TBL] [Abstract][Full Text] [Related]
8. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma. Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363 [TBL] [Abstract][Full Text] [Related]
9. Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma. Liu Y; Poon RT; Feng X; Yu WC; Luk JM; Fan ST Am J Gastroenterol; 2004 Jun; 99(6):1111-21. PubMed ID: 15180734 [TBL] [Abstract][Full Text] [Related]
10. [Experimental study on the activity of Staphyloccocal enterotoxin A liposome for inducing cytotoxicity of TIL from human hepatocellular carcinoma against tumor cells]. Li MD; Li ZY; He S; Xue H Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):64-7. PubMed ID: 14981818 [TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133 [TBL] [Abstract][Full Text] [Related]
12. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208 [TBL] [Abstract][Full Text] [Related]
13. Phenotypical and functional differences of tumor-infiltrating lymphocytes from human colorectal cancers induced by costimulation with rIL-2 and rIL-4 in vitro. Keller H; Wimmenauer S; Rahner S; Von Kleist S; Farthmann EH Anticancer Res; 1996; 16(6B):3565-70. PubMed ID: 9042222 [TBL] [Abstract][Full Text] [Related]
14. Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor. Yoshino I; Yano T; Murata M; Ishida T; Sugimachi K; Kimura G; Nomoto K Cancer Res; 1992 Feb; 52(4):775-81. PubMed ID: 1737336 [TBL] [Abstract][Full Text] [Related]
15. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck. Heo DS; Whiteside TL; Johnson JT; Chen KN; Barnes EL; Herberman RB Cancer Res; 1987 Dec; 47(23):6353-62. PubMed ID: 3315186 [TBL] [Abstract][Full Text] [Related]
17. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077 [TBL] [Abstract][Full Text] [Related]
18. Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes. Wang YL; Si LS; Kanbour A; Herberman RB; Whiteside TL Cancer Res; 1989 Nov; 49(21):5979-85. PubMed ID: 2507139 [TBL] [Abstract][Full Text] [Related]
19. Human tumor-infiltrating CD4+ T cells react to B cell lines expressing heat shock protein 70. Yoshino I; Goedegebuure PS; Peoples GE; Lee KY; Eberlein TJ J Immunol; 1994 Nov; 153(9):4149-58. PubMed ID: 7930618 [TBL] [Abstract][Full Text] [Related]
20. Postoperative immunotherapy for patients with hepatocarcinoma using tumor-infiltrating lymphocytes. Wang Y; Chen H; Wu M; Bao J; Cong W; Wang H Chin Med J (Engl); 1997 Feb; 110(2):114-7. PubMed ID: 9594281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]